ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

STX Shield Therapeutics Plc

1.325
-0.10 (-7.02%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -7.02% 1.325 1.30 1.35 1.425 1.325 1.425 2,958,047 14:52:56
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.25 10.24M

Shield Therapeutics PLC Price Monitoring Extension (9083G)

26/07/2019 2:00pm

UK Regulatory


Shield Therapeutics (LSE:STX)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Shield Therapeutics Charts.

TIDMSTX

RNS Number : 9083G

Shield Therapeutics PLC

26 July 2019

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

PMEXQLFLKDFBBBB

(END) Dow Jones Newswires

July 26, 2019 09:00 ET (13:00 GMT)

1 Year Shield Therapeutics Chart

1 Year Shield Therapeutics Chart

1 Month Shield Therapeutics Chart

1 Month Shield Therapeutics Chart

Your Recent History

Delayed Upgrade Clock